Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
Cantor Fitzgerald
Healthtrust
Farmers Insurance
Accenture

Generated: March 21, 2019

DrugPatentWatch Database Preview

Braintree Company Profile

« Back to Dashboard

Summary for Braintree
International Patents:20
US Patents:3
Tradenames:7
Ingredients:6
NDAs:6
Patent Litigation for Braintree: See patent lawsuits for Braintree

Drugs and US Patents for Braintree

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Braintree NULYTELY-FLAVORED polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride FOR SOLUTION;ORAL 019797-002 Nov 18, 1994 AA RX Yes Yes ➤ Sign Up ➤ Sign Up
Braintree Labs SUCLEAR magnesium sulfate; polyethylene glycol 3350; potassium chloride; potassium sulfate; sodium bicarbonate; sodium chloride; sodium sulfate SOLUTION;ORAL 203595-001 Jan 18, 2013 DISCN Yes No ➤ Sign Up ➤ Sign Up
Braintree AXID nizatidine SOLUTION;ORAL 021494-001 May 25, 2004 DISCN Yes No 6,930,119 ➤ Sign Up Y ➤ Sign Up
Braintree GOLYTELY polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 019011-001 Jul 13, 1984 AA RX Yes Yes ➤ Sign Up ➤ Sign Up
Braintree GOLYTELY polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 019011-002 Jun 2, 1992 RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for BRAINTREE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe For Oral Solution and Delayed-release Tablet 210 g, 5.6 g, 0.74 g, 2.86 g and 5 mg (1 Tablet Regimen) ➤ Subscribe 2010-07-30
➤ Subscribe Oral Solution 17.5 g/3.13 g/1.6 g per bottle ➤ Subscribe 2010-11-08
➤ Subscribe For Oral Solution and Delayed- 210 g, 5.6 g, 0.74 g, 2.86 g and 5 mg ➤ Subscribe 2008-01-28
➤ Subscribe Oral Solution 15 mg/mL ➤ Subscribe 2008-05-14

Supplementary Protection Certificates for Braintree Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1499331 13C0055 France ➤ Sign Up PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220
0984957 C300517 Netherlands ➤ Sign Up PRODUCT NAME: ACETYLSALICYLZUUR EN ESOMEPRAZOLMAGNESIUMTRIHYDRAAT; NAT. REGISTRATION NO/DATE: RVG 107516 20110912; FIRST REGISTRATION: 540235954023675402375 2011120812
1499331 2013C/049 Belgium ➤ Sign Up PRODUCT NAME: EZICLEN, CONCENTRE POUR BOISSON; AUTHORISATION NUMBER AND DATE: BE434323 20130220
0984957 CR 2012 00035 Denmark ➤ Sign Up PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105
0984957 C300483 Netherlands ➤ Sign Up PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMTRIHYFRAAT; NAT. REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: PL 17091/0263 - 0001 20110524
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chinese Patent Office
Citi
Teva
Harvard Business School
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.